logoThe People's Perspective on Medicine

Could Dementia Genes Make You Vulnerable to COVID-19?

Researchers have found that dementia genes are twice as common among hospitalized COVID-19 patients as in the general population.
Could Dementia Genes Make You Vulnerable to COVID-19?
Disabled elderly female with a grey blanket on isolated background flu symptoms

Investigators are trying to determine why some people remain asymptomatic after catching the SARS-2 virus while others become deathly ill. Could dementia genes make a difference?

The e4 variant of the APOE gene is linked to a higher risk of Alzheimer’s disease. All of us have some form of apolipoprotein E, termed APOE for short. It comes in several varieties, including e2 (which reduces risk of Alzheimer disease), e3 which is the most common form and e4 (which increases risk for Alzheimer disease, especially for people with two copies of e4) (Nature Reviews. Neurology, Feb. 2013). Because genes come in pairs, everyone has two copies, but they don’t have to match.

Dementia Genes and COVID-19:

British scientists have just reported that people with two copies of the e4 gene variant may also be at greater risk for COVID-19 (Journal of Gerontology: Medical Sciences, May 26, 2020). To determine this, they used genetic data on more than 450,000 people of European ancestry in the UK Biobank. Roughly 9,000 of these Britons carried two copies of the e4 type of APOE. That amounts to approximately 2 percent. Alarmingly, however, among those who had tested positive for COVID-19, more than 5 percent had two copies of the e4 variant. As a result, the researchers concluded that people with two e4 APOE genes were about twice as likely to have become infected as those with the more common e3 variants.

The lead investigator noted that people with dementia are at especially high risk of developing severe COVID-19. While some of that could be explained by the virus spreading through long-term care facilities, the connection with the double e4 gene variant may also play a role.

Other researchers urge caution, however. Although the percentage of those with COVID-19 is high, the actual total number is very small. Only 37 people fell into this category. Consequently, more research is needed to confirm this link.

Rate this article
star-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-empty
4.4- 32 ratings
About the Author
Terry Graedon, PhD, is a medical anthropologist and co-host of The People’s Pharmacy radio show, co-author of The People’s Pharmacy syndicated newspaper columns and numerous books, and co-founder of The People’s Pharmacy website. Terry taught in the Duke University School of Nursing and was an adjunct assistant professor in the Department of Anthropology. She is a Fellow of the Society of Applied Anthropology. Terry is one of the country's leading authorities on the science behind folk remedies. .
Get the latest health news right in your inbox

Join our daily email newsletter with breaking health news, prescription drug information, home remedies AND you'll get a copy of our brand new full-length health guide — for FREE!

Screenshots of The People's Pharmacy website on mobile devices of various sizes
Citations
  • Liu C-C et al, "Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy." Nature Reviews. Neurology, Feb. 2013. DOI: 10.1038/nrneurol.2012.263
  • Kuo C-L et al, "APOE e4 genotype predicts severe COVID-19 in the UK Biobank community cohort." Journal of Gerontology: Medical Sciences, May 26, 2020. https://doi.org/10.1093/gerona/glaa131
Join over 150,000 Subscribers at The People's Pharmacy

We're empowering you to make wise decisions about your own health, by providing you with essential health information about both medical and alternative treatment options.